Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 11 | ECE2006 | Next issue

8th European Congress of Endocrinology incorporating the British Endocrine Societies

Poster Presentations

Clinical practise and governance

Previous section
Clinical case reports
Table of contents
Next section
Comparative endocrinology

ea0011p175 | Clinical practise and governance

Audit on management of chronic adrenal insufficiency

ea0011p176 | Clinical practise and governance

Salivary cortisol daycurve and Quality of Life assessment in optimizing glucocorticoid replacement therapy in patients with Addison’s disease

ea0011p177 | Clinical practise and governance

Symptom-specific thresholds for testosterone deficiency modulate complaints and metabolic risk in 434 aging male patients

ea0011p178 | Clinical practise and governance

Longterm experience of more than 8 years with a novel formulation of testosterone undecanoate (Nebido) in substitution therapy of hypogonadal men

ea0011p179 | Clinical practise and governance

Improvements for patients and nurses using 2.5 ml prefilled syringes as the vehicle solution for suspension of Sandostatin LAR® microspheres

ea0011p180 | Clinical practise and governance

Impaired thirst and AVP release due to a reset osmostat in a patient with partial cranial diabetes insipidus (CDI) and subtle pituitary disease

ea0011p181 | Clinical practise and governance

Reactive hypoglycaemia – can measuring insulin concentrations help understand the pathophysiology and support diagnosis?

ea0011p182 | Clinical practise and governance

Impaired quality of life in patients with adrenal insufficiency – evidence that improved glucocorticoid replacement strategies are needed

ea0011p183 | Clinical practise and governance

Long-acting, intramuscular TestosteronE undecanoatE (TU, Nebido®) in the treatment of female-to-male transgender individuals

ea0011p184 | Clinical practise and governance

Long-acting intramuscular testosterone undecanoate (TU, Nebido®) in treatment of hypogonadal aging males

ea0011p185 | Clinical practise and governance

Screening in primary care using fasting glucose uncovers significant hypoglycaemia including an asymptomatic insulinoma

ea0011p186 | Clinical practise and governance

Comparison of the effect of sibutramine monotherapy with sibutramine-metformin combination therapy in nondiabetic obese women

ea0011p187 | Clinical practise and governance

Torbay adrenal and pituitary project

ea0011p188 | Clinical practise and governance

Autoimmune hypoadrenalism: the profile of related conditions

ea0011p189 | Clinical practise and governance

Recombinant hGH therapy in males with organic GHD: should we trust in total testosterone levels for diagnosis of central hypogonadism?

ea0011p190 | Clinical practise and governance

Survey of steroid replacement therapy

ea0011p191 | Clinical practise and governance

Concordance between GH determination and IGF-I in acromegaly using two IGF-I methods

ea0011p192 | Clinical practise and governance

Adult turner syndrome clinic: what are the patients’ perceptions of this specialist service?

ea0011p193 | Clinical practise and governance

Adequacy of post-glucose gh nadir <1 μg/l to define biochemical and neuroradiological remission of acromegaly

ea0011p194 | Clinical practise and governance

Patients with serum prolactin >20,000 mU/l – review of presentation, management and outcome

ea0011p195 | Clinical practise and governance

Long-term outcome in men with microprolactinoma

ea0011p196 | Clinical practise and governance

Ophthalmic findings in turner syndrome

ea0011p197 | Clinical practise and governance

Early detection of diabetic autonomic neuropathy with a new device

ea0011p198 | Clinical practise and governance

Adult growth hormone replacement therapy after the institution of NICE guidelines

ea0011p199 | Clinical practise and governance

Clinical evaluation of sheehan syndrome

ea0011p200 | Clinical practise and governance

Is a repeat or resting prolactin necessary in the investigation of hyperprolactinaemia?

ea0011p201 | Clinical practise and governance

Knowledge of testosterone replacement therapy is significantly correlated with patient satisfaction suggesting greater need for education

ea0011p202 | Clinical practise and governance

Cushing’s disease – an audit of outcomes following pituitary surgery from a single centre

ea0011p203 | Clinical practise and governance

Clinical characterization of patients with hyperprolactinaemia due to macroprolactin

ea0011p204 | Clinical practise and governance

Total cortisol and calculated free cortisol during the 250 μg ACTH test

ea0011p205 | Clinical practise and governance

Comparison of the effects of transdermal and oral oestrogen treatments on serum and salivary cortisol concentrations

ea0011p206 | Clinical practise and governance

A survey of gender dysphoria (transsexual) patients attending an endocrine clinic

ea0011p207 | Clinical practise and governance

Osteoporosis, osteopaenia and osteoarthritis in autoimmune hypoadrenalism

ea0011p208 | Clinical practise and governance

Autoimmune hypoadrenalism: symptoms at diagnosis

ea0011p209 | Clinical practise and governance

Does HT still have a place? The impact on menopausal-related symptoms

ea0011p210 | Clinical practise and governance

High mortality rate in hospital inpatients with hyponatraemia

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more